Q1 2025
|
27 |
356,489 |
CGON, NUVB, AARDVARK THERAPEUTICS INC, UPB
|
13F-HR
|
5/7/2025 |
000110465925045686 |
Q4 2024
|
28 |
466,229 |
CGON, NUVB, Upstream Bio Inc., NAMS
|
13F-HR
|
2/14/2025 |
000110465925013870 |
Q3 2024
|
26 |
422,193 |
CGON, NUVB, PHAT, RCUS
|
13F-HR
|
11/14/2024 |
000110465924119361 |
Q2 2024
|
24 |
326,315 |
CGON, NUVB, RCUS, ZNTL
|
13F-HR
|
8/14/2024 |
000110465924089453 |
Q1 2024
|
22 |
745,647 |
ALPN, CG ONCOLOGY INC, ZNTL, ILMN
|
13F-HR
|
5/13/2024 |
000110465924060707 |
Q4 2023
|
24 |
357,920 |
ALPN, ZNTL, PACB, TXG
|
13F-HR
|
2/12/2024 |
000110465924014002 |